Literature DB >> 6588242

Secondary hyperparathyroidism and glucose intolerance in children with uremia.

R H Mak, C Turner, G B Haycock, C Chantler.   

Abstract

Glucose metabolism was studied using the glucose clamp technique in 8 children with CRF (4 pubertal and 4 prepubertal) before and after correction of secondary hyperparathyroidism (HPD) by a regime of phosphate binders and dietary phosphate restriction. Glucose metabolic rate (M) increased by 34%, insulin response (I) increased by 32%, and insulin sensitivity (M/I) did not change. Compared to corresponding normal values, these patients were glucose-intolerant (low M) before treatment and became glucose-tolerant after treatment (normal M). They were insulin-resistant (low M/I) before treatment and remained so after treatment. The 5 uremic children without secondary HPD were treated with the same regime to prevent the secondary HPD. Their M, I, and M/I did not change after treatment. The change in I correlated closely with the change in M in all 13 patients. One pubertal patient with uremia was studied on three occasions. Initially, without secondary HPD, he had a normal M and a low M/I. When he developed secondary HPD, M decreased by 39%, I decreased by 37%, and M/I did not change. Treatment of his secondary HPD restored M and I values back to initial levels, and M/I again did not change. Treatment of secondary HPD by correction of phosphate retention led to an improvement of glucose intolerance with an increase in insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6588242

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  11 in total

1.  Evaluation of long-term aggressive dietary management of chronic renal failure in children.

Authors:  K F Jureidini; R J Hogg; M J van Renen; T R Southwood; P H Henning; L Cobiac; L Daniels; S Harris
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 2.  Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis.

Authors:  Ravi Iyengar; Jennifer Franzese; Roma Gianchandani
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

Review 3.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

4.  The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease.

Authors:  Georges Saab; Adam Whaley-Connell; Andrew Bombeck; Manjula Kurella Tamura; Suying Li; Shu-Cheng Chen; Samy I McFarlane; James R Sowers; Keith Norris; George L Bakris; Peter A McCullough
Journal:  Cardiorenal Med       Date:  2011-04-15       Impact factor: 2.041

Review 5.  Carbohydrate metabolism in uremia.

Authors:  R H Mak
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 6.  Insulin and its role in chronic kidney disease.

Authors:  Robert H Mak
Journal:  Pediatr Nephrol       Date:  2007-10-11       Impact factor: 3.714

7.  Insulin and growth in chronic renal failure.

Authors:  R H Mak; G B Haycock; C Chantler
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

8.  Parathyroid hormone suppresses insulin signaling in adipocytes.

Authors:  Eugene Chang; Shawn S Donkin; Dorothy Teegarden
Journal:  Mol Cell Endocrinol       Date:  2009-04-09       Impact factor: 4.102

Review 9.  Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease.

Authors:  Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Semin Nephrol       Date:  2021-03       Impact factor: 5.299

Review 10.  Insulin resistance in patients with chronic kidney disease.

Authors:  Min-Tser Liao; Chih-Chien Sung; Kuo-Chin Hung; Chia-Chao Wu; Lan Lo; Kuo-Cheng Lu
Journal:  J Biomed Biotechnol       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.